Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Org Chem ; 65(20): 6418-22, 2000 Oct 06.
Article in English | MEDLINE | ID: mdl-11052083

ABSTRACT

The intramolecular [2 + 2] photocycloaddition of bismaleimides leads to cage diimides 2. Nucleophilic addition on these compounds (NaBH4, RLi, or MeONa) gives rise to various diazatetracyclic 4 and 11 or oxadiazapentacyclic 3 "bowl shaped" alcohols. X-ray analyses of 3c and 11a provide definite structural data concerning these two highly functionalized compounds.

2.
J Pharm Pharmacol ; 52(3): 289-96, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10757416

ABSTRACT

This study was designed to test the hypothesis that lipophilic cationic drugs with only roughly similar structures mediate the reversal of multidrug-resistance (MDR) by interacting with membrane phospholipids. The permeation properties of MDR-modulators and non-modulators were studied by quantifying their ability to induce the leakage of Sulphan blue through the membrane of negatively charged unilamellar liposomes. Of the 22 compounds under investigation, only those bearing a net positive electric charge per molecule (z) > or = 0.2 induced dye leakage. All these efficient drugs are well-known MDR-modulators: calcium-channel blockers (propranolol, verapamil, diltiazem and dipyridamole), calmodulin antagonists (clomipramine and thioridazine) and antiparasitic agents (mepacrine, thioacridine derivatives and quinine). The non-modulators tested, including antineoplastic agents and steroids, did not induce any membrane permeation. The permeation process was a co-operative one (1.1 < Hill coefficient < 4.1) and the permeation doses inducing 50% dye leakage (PD50) were 1.9-11.2 mM. The permeation ability of the MDR-modulators (log(1/PD50)) increased significantly with octanol-buffer distributions per unit net electric charge ((logD)/z). The results provide evidence that a complex interplay occurs between the electric charge and the lipophilicity of the MDR-modulators when a dye leakage is induced through model membranes, and probably also when the MDR is reversed in leukaemic cells.


Subject(s)
Drug Resistance, Multiple , Lipid Bilayers/chemistry , Anti-Inflammatory Agents/chemistry , Antineoplastic Agents/chemistry , Antiparasitic Agents/chemistry , Buffers , Calcium Channel Blockers/chemistry , Chemical Phenomena , Chemistry, Physical , Clomipramine/chemistry , Liposomes/chemistry , Octanols , Permeability , Pharmaceutical Preparations/chemistry , Steroids , Thioridazine/chemistry
3.
J Med Chem ; 42(26): 5448-54, 1999 Dec 30.
Article in English | MEDLINE | ID: mdl-10639286

ABSTRACT

Series of 9-amino and 9-thioacridines have been synthesized and studied as inhibitors of trypanothione reductase (TR) from Trypanosoma cruzi, the causative agent of Chagas' disease. The compounds are structural analogues of the acridine drug mepacrine (quinacrine), which is a competitive inhibitor of the parasite enzyme, but not of human glutathione reductase, the closest related host enzyme. The 9-aminoacridines yielded apparent K(i) values for competitive inhibition between 5 and 43 microM. The most effective inhibitors were those with the methoxy and chlorine substituents of mepacrine and NH(2) or NHCH(CH(3))(CH(2))(4)N(Et)(2) at C9. Detailed kinetic analyses revealed that in the case of 9-aminoacridines more than one inhibitor molecule can bind to the enzyme. In contrast, the 9-thioacridine derivatives inhibit TR with mixed-type kinetics. The kinetic data are discussed in light of the three-dimensional structure of the TR-mepacrine complex. The conclusion that structurally very similar acridine compounds can give rise to completely different inhibition patterns renders modelling studies and quantitative structure-activity relationships difficult.


Subject(s)
Acridines/pharmacology , Enzyme Inhibitors/pharmacology , NADH, NADPH Oxidoreductases/antagonists & inhibitors , Trypanosoma cruzi/drug effects , Acridines/chemistry , Animals , Enzyme Inhibitors/chemistry , Kinetics , Magnetic Resonance Spectroscopy , Structure-Activity Relationship , Trypanosoma cruzi/enzymology
4.
Anticancer Res ; 18(4C): 3011-5, 1998.
Article in English | MEDLINE | ID: mdl-9713501

ABSTRACT

The antiviral effect of 22 acridine derivatives was studied on the multiplication of herpes simplex virus type 2 (HSV-2) in Vero cells. The inhibitory effect of four acridine derivatives on the multiplication of HSV-2 is emphasised, six other compounds have moderate activity and three only slightly affect the virus multiplication, while nine compounds are inactive. Some of the effective derivatives inhibit the virus replication without any direct effect on the virus particles. However, the mechanism of the antiviral effect is still not known.


Subject(s)
Acridines/pharmacology , Antiviral Agents/pharmacology , Herpesvirus 2, Human/drug effects , Virus Replication/drug effects , Animals , Chlorocebus aethiops , Herpesvirus 2, Human/physiology , Microbial Sensitivity Tests , Structure-Activity Relationship , Vero Cells
5.
Anticancer Res ; 18(4C): 3053-8, 1998.
Article in English | MEDLINE | ID: mdl-9713509

ABSTRACT

We studied the effect of thioacridine derivatives on the function of P-glycoprotein in MDR mouse T-lymphoma cell line L5178 and in MDR human leukemia cell line K562/ADR by rhodamine 123 uptake assay. The effect of some selected thioacridines was also investigated on the expression of the mdr1 gene. Expression was analysed by RT-PCR. Two compounds: 3-amino-9-thio-(4'-nitrobenzyl)acridinone and 2,7-dimethoxy-9-thio-(2'-diethylaminoethyl) acridinone were able to block the function of the P-gp, and also to decrease significantly mdr1 gene expression. Because these two derivatives exert their positive effects as reversing agents they could be potential candidate anticancer agents for further investigation. The thioacridines, which do not affect P-gp function, do not affect or increase the expression of mdr1 gene. Our results showed the structure-activity relationships of these compounds, providing a direction for the development of new, more active compounds.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/drug effects , ATP Binding Cassette Transporter, Subfamily B, Member 1/physiology , Acridines/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Animals , Coloring Agents/pharmacokinetics , Drug Resistance, Multiple , Gene Expression/drug effects , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/metabolism , Mice , Polymerase Chain Reaction , RNA, Neoplasm/biosynthesis , RNA, Neoplasm/metabolism , Rhodamine 123 , Rhodamines/pharmacokinetics , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...